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Abstract
This study investigated the role of prion infection of the olfactory mucosa in the shedding of prion infectivity into nasal
secretions. Prion infection with the HY strain of the transmissible mink encephalopathy (TME) agent resulted in a prominent
infection of the olfactory bulb and the olfactory sensory epithelium including the olfactory receptor neurons (ORNs) and
vomeronasal receptor neurons (VRNs), whose axons comprise the two olfactory cranial nerves. A distinct glycoform of the
disease-specific isoform of the prion protein, PrP
Sc, was found in the olfactory mucosa compared to the olfactory bulb, but
the total amount of HY TME infectivity in the nasal turbinates was within 100-fold of the titer in the olfactory bulb. PrP
Sc co-
localized with olfactory marker protein in the soma and dendrites of ORNs and VRNs and also with adenylyl cyclase III, which
is present in the sensory cilia of ORNs that project into the lumen of the nasal airway. Nasal lavages from HY TME-infected
hamsters contained prion titers as high as 10
3.9 median lethal doses per ml, which would be up to 500-fold more infectious
in undiluted nasal fluids. These findings were confirmed using the rapid PrP
Sc amplification QuIC assay, indicating that nasal
swabs have the potential to be used for prion diagnostics. These studies demonstrate that prion infection in the olfactory
epithelium is likely due to retrograde spread from the olfactory bulb along the olfactory and vomeronasal axons to the
soma, dendrites, and cilia of these peripheral neurons. Since prions can replicate to high levels in neurons, we propose that
ORNs can release prion infectivity into nasal fluids. The continual turnover and replacement of mature ORNs throughout the
adult lifespan may also contribute to prion shedding from the nasal passage and could play a role in transmission of natural
prion diseases in domestic and free-ranging ruminants.
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Introduction
Recent evidence indicates that natural prion diseases such as
scrapie in sheep and chronic wasting disease in cervids, which
cause a progressive fatal neurodegeneration, can be highly
contagious [1,2]. In a large scale study of hunter harvested cervids
in the 1990’s, the Colorado Division of Wildlife reported a CWD
infection rate of 4.9% in mule deer, 2.1% in white tailed deer, and
0.5% in elk [3]. An even higher prevalence rate for CWD infection
is found in the core area of infection in south central Wisconsin
where the prevalence of CWD in adult buck white-tail deer was
15.5% in 2008 [4]. In cervid game farms the prevalence of CWD
infection can vary widely, but has been reported as high as 83% in
white-tail deer and 67% in captive mule deer [1,2]. Similarly, in
domestic sheep there is a genetic predisposition for scrapie among
certain breeds [5–8] and the annual prevalence of disease can
range from less than one percent to greater than 20% in adults
[9,10]. In a recent report, the culling and testing of two
endemically infected flocks revealed that 58% of sheep were
positive for the abnormal isoform of the prion protein, PrP
Sc,
despite a very low number of clinical scrapie cases [11]. These
infection rates indicate that a relatively high percent of certain
sheep breeds and North American deer in endemic areas can have
a subclinical prion infection, but that typically only a small percent
of animals exhibit symptoms of disease at a given time. These
studies also suggest that these prion diseases have the potential to
be highly contagious under certain conditions, which are not
completely understood (e.g., animal density, number of contacts,
prion protein genotype, etc). Despite these recents developments in
identifying a high prevalence of infection for scrapie and CWD in
domestic and free-ranging ruminants, the mode(s) of prion
transmission among hosts is not well understood.
Recent evidence indicates that scrapie can be transmitted via
milk from an infected ewe to lambs from a scrapie-negative flock,
possibly via infected macrophages [12,13]. Other studies have
found scrapie infection in placenta from infected ewes and
although infection does not appear to transmit in utero, after
birthing, placenta could lead to infection of newborn lambs or
contaminate the environment for subsequent horizontal transmis-
sion [14,15]. These sources of prion infectivity have not been
confirmed in CWD infected cervids, but in both prion diseases,
blood does contain prion infectivity [16,17]. However, blood
borne prion transmission via vectors or other mechanisms has not
been reported in ruminants. Recent studies demonstrate the
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infected deer or rodent prion models, and successful transmission
of CWD to deer has been achieved following experimental oral
ingestion of saliva obtained from infected deer [17,18]. Feces from
CWD-infected deer have also been demonstrated to contain prion
infectivity, although the amount of infectious agent was extremely
low [19]. It has not been resolved whether infection from these
fluids and tissues can directly or indirectly transmit prion infection
in natural settings, but environmental contaminants are also likely
sources for prion transmission [20]. In addition to exposure to
prion agent, the dose of agent exposure is likely to be a primary
factor in determining disease transmission. The reported amount
of prion infectivity in saliva, urine, milk, and feces from prion-
infected animals is very low [17–19,21].
Since neurons are a principal target of prion infection and the
brain has the highest amount of prion infectivity, we propose that
peripheral neurons located at mucosal surfaces can replicate
prions to high levels and release prion infectivity into mucosal
fluids. The olfactory mucosa has previously been demonstrated to
be a site of prion infection in animals and humans [22,23] and it
contains olfactory receptor neurons, which are a population of
neurons that continue to turnover and replenish during adult life.
Prior studies have demonstrated that the olfactory epithelium,
vomeronasal epithelium, nerve bundles, and/or nasal associated
lymphoid tissue is a target for prion infection in humans with
classical Creutzfeldt-Jakob disease, sheep scrapie, deer and elk
with CWD, or in rodent models of prion infection [22–28]. In the
present study we investigated the cell type and location of prion
infection in the olfactory mucosa of hamsters infected with the HY
strain of transmissible mink encephalopathy (TME) [29] as well as
the amount of prion infectivity in the olfactory mucosa and in
nasal fluids. Our findings indicate that olfactory or vomeronasal
receptor neurons are the principal, and perhaps only, site of prion
infection in the sensory epithelium. The olfactory mucosa
contained high amounts of prion infectivity while nasal fluids
had low-to-moderate levels. The presence of prion infection in the
cilia of olfactory neurons suggests that prion infectivity can be
released into the lumen of the nasal airway, possibly during the
normal and frequent turnover of these neurons. Our studies
suggest that prion infection of olfactory receptor neurons can result
in shedding of prion infectivity into nasal fluids, which may
contribute to prion transmission to naı ¨ve hosts.
Results
Prion infection of olfactory system
To test for the presence of olfactory receptor neurons (ORNs) in
the olfactory bulb and olfactory mucosa of Syrian golden
hamsters, tissue lysates from the cerebellum-brainstem, olfactory
bulb, and olfactory mucosa after extraction from the nasal
turbinates were assayed for olfactory marker protein (OMP) by
western blot (Figure 1A). Both the olfactory bulb and olfactory
mucosa had comparable levels of OMP (a 19 kilodalton protein)
on a per protein basis, but the cerebellum-brainstem homogenate,
which does not contain ORNs, did not have evidence of OMP
immunoreactivity (Figure 1A, lanes 1, 4 and 7). To investigate
prion infection of the olfactory system, initially the level of PrP
C
was measured in these same tissues. A western blot for PrP
C in
tissue homogenates from age-matched, normal mock-infected
hamsters revealed the typical pattern of PrP
C polypeptides, whose
major polypeptides range from 33 to 35 kilodalton (kDa), in lysates
from the cerebellum-brainstem and olfactory bulb (Figure 1B,
lanes 1, 4). The amount of PrP
C in these parts of the brain was
four to eight times greater than in the olfactory mucosa (Figure
S1). In the olfactory mucosa, the typical brain-associated PrP
C
polypeptides were not found, but two major immunoreactive anti-
PrP 3F4 polypeptides, at approximately 25 and 31 kDa, were
present (Figure 1B, lane 7). Enzymatic deglycosylation of PrP
C in
olfactory bulb and nasal turbinate lysates produced a single
immunoreactive polypeptide at approximately 27.8 kDa, indicat-
ing that the differences in PrP
C molecular weight between these
tissues was primarily due to the extent and/or types of N-linked
glycosylation (Figure S2). Differences in the major PrP
C
polypeptides between olfactory bulb and olfactory mucosa lysates
were also observed using anti-PrP monoclonal antibody SAF-32
(Figure S1). Our findings are consistent with a previous study that
described a distinct PrP
C glycosylation pattern in extracts of the
murine nasal mucosa [30]. These findings demonstrate high levels
of PrP
C in the olfactory bulb and also a distinct PrP
C polypeptide
pattern in the olfactory mucosa compared to the olfactory bulb
and brain.
To directly test the susceptibility of the olfactory system to prion
infection, Syrian golden hamsters were inoculated with the HY
TME agent by either the intracerebral (i.c.) or intra-olfactory bulb
(i.ob.) routes. Following i.c. inoculation of 10
6.1 i.c. median lethal
doses (LD50) or i.ob. of 10
5.6 i.c. LD50, the incubation periods were
7563.2 days (N=6) and 9163.5 days (N=6), respectively (p-
value,0.001, one-sided t-test). Western blot for total PrP
(Figure 1B) and proteinase K (PK)-resistant PrP
Sc (Figure 1C) in
normal, mock-infected (lanes 1, 4, 7) and HY TME-infected
hamsters following i.c. (lanes 2, 5, 8) and i.ob. (lanes 3, 6, 9)
inoculation revealed higher levels of total PrP in infected tissue
homogenates than in mock-infected tissues, and the presence of
PK-resistant PrP
Sc in the cerebellum-brainstem and olfactory bulb
from HY TME hamsters, but not in mock-inoculated hamster
tissues. PK-resistant PrP
Sc was also found at lower levels in the
olfactory mucosa of HY TME-infected hamsters from both the i.c.
and i.ob. groups compared to the amount in the brain based on
PK digestion of 100 mg of protein from each tissue, but it was not
detected in olfactory mucosa of the mock-infected hamster group
(Figure 1C, lanes 7 to 9). The PrP
Sc polypeptide pattern in the
olfactory mucosa was represented by a single polypeptide at
Author Summary
Prion diseases are fatal neurodegenerative diseases and in
ruminants they can be highly contagious, yet the route of
transmission among sheep with scrapie or deer with
chronic wasting disease is not completely understood. In
this study, we examined the hypothesis that prion
infection in peripheral neurons that are located at a
mucosal surface can result in the release of prion infectivity
into bodily secretions. Our findings indicate that prion
infection of the olfactory system leads to a high level of
infection of olfactory neurons in the sensory epithelium of
the nasal cavity, likely by retrograde spread in the olfactory
nerve. Prions were also located in the sensory cilia of
olfactory neurons and since these structures project into
the airway of the nasal cavity, we were able to detect
moderate levels of prion infectivity in nasal secretions.
These findings demonstrate how prions can disseminate
within a host to a peripheral neuron at the mucosa and
subsequently release infectivity into bodily fluids. Further-
more, olfactory sensory neurons undergo a continual
turnover throughout the adult lifespan and the loss of
prion-infected neurons at the olfactory mucosa could also
result in continuous shedding of prion infectivity and serve
as a mechanism for disease transmission.
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was characteristic of the agycosylated, monoglycosylated and
diglycosylated PrP
Sc polypeptides present in brain and olfactory
bulb (these range in molecular weight from approximately 20 to
30 kilodaltons). These findings indicate that HY TME infection
resulted in a high level of PrP
Sc deposition in the olfactory bulb,
but a lower level in the olfactory mucosa where a distinct pattern
of PrP
Sc polypeptides was found.
To further define the characteristics of PrP
Sc in the olfactory
system, PK-resistant PrP
Sc was enriched from lysates of the
olfactory bulb and olfactory mucosa by detergent extraction and
ultracentrifugation. This revealed a distinct pattern of PK-resistant
PrP
Sc polypeptides in the olfactory mucosa extracted from nasal
turbinates of HY TME infected hamsters (Figure 2). In this
experiment one predominant PrP
Sc polypeptide was found in the
olfactory mucosa extracts at approximately 26.6 kDa, while
weaker intensity PrP
Sc polypeptides were observed at 22.2 and
28 kDa (Figure 2, lanes 5 to 8). This was distinct from the olfactory
bulb where the a-, mono- and di-glycosylated PrP
Sc polypeptides
had molecular weights of 18.4 kDa, 23.4 kDa, and 29.1 kDa
(Figure 2A, lanes 1 to 4), which were similar to the PrP
Sc
polypeptide pattern in the brain (Figure 1C). No differences in the
PrP
Sc polypeptide pattern were observed between hamsters that
were inoculated by the i.c. route (Figure 2, lanes 1, 2, 5, and 6)
versus the i.ob. route (Figure 2, lanes 3, 4, 7, and 8). These findings
suggest that the processing and/or formation of PrP
Sc in the
olfactory mucosa was distinct from the olfactory bulb and brain.
Prion infection of olfactory receptor neurons
To investigate the sites of HY TME infection in the olfactory
system, immunohistochemistry (IHC) was performed on the
olfactory bulb and nasal cavity in hamsters following i.ob.
inoculation of the HY TME agent. In clinical hamsters, there
was a strong PrP
Sc deposition pattern in the main olfactory bulb,
most prominently in the mitral and granule cell layers, external
and internal plexiform layers and glomerular layer (Figure 3A, 3B
and 3C), but immunostaining was not observed in the olfactory
bulb of normal, mock-infected hamsters (Figure S3A). There was a
notable absence of PrP
Sc deposition in the outer nerve layer, which
contains the axons of the ORNs whose cell bodies are located in
the olfactory sensory epithelium (OSE) of the olfactory mucosa.
Figure 1. Western blot for olfactory marker protein and prion
protein in brainstem, olfactory bulb, and olfactory mucosa
following HY TME infection of hamsters. Tissue from age-matched,
mock-infected (lanes 1, 4, 7) and HY TME-infected (lanes 2, 3, 5, 6, 8, 9)
hamsters following intracerebral (lanes 2, 5, 8), and intra-olfactory bulb
(lanes 1, 3, 4, 6, 7, 9) inoculation were homogenized and 50 (A, B)o r1 0 0( C)
micrograms of protein was analyzed per lane. In C, protein samples were
digested with 10 ug/ml of proteinase K for 37uC for 1 hour prior to SDS-
PAGE. This treatment removes PrP
C in mock-infected samples and
truncates PrP
Sc in HY TME lysates. Total prion (PrP) protein (B) and PrP
Sc
(C) was immunodetected with anti-PrP 3F4 monoclonal antibody, while
olfactory marker protein (A) was immunodetected with polyclonal goat
serum to OMP. OMP is present in both the olfactory bulb, which contains
the olfactory nerve andterminals,andin theolfactory mucosathat contain
the soma, dendrites, and axons of ORNs. Marker (M) polypeptides
correspond to 20, 30, and 40 kDa. The short vertical tick marks at the
top and bottom of each panel are placed before lanes 4 and 7 in order to
align lanes between each panel.
doi:10.1371/journal.ppat.1000837.g001
Figure 2. Western blot for PrP
Sc in olfactory bulb and olfactory
mucosa following HY TME infection of hamsters. Olfactory bulb
(lanes 1 to 4) and olfactory mucosa (lanes 5 to 8) lysates from clinical HY
TME hamsters following intracerebral (lanes 1, 2, 5 and 6) and intra-
olfactory bulb (lanes 3, 4, 7, and 8) inoculation were enriched for PrP
Sc
by detergent extraction, ultracentrifugation, and proteinase K digestion.
Western blot for prion protein was performed as described in Figure 1.
Marker (M) polypeptides correspond to 20, 30, and 40 kDa.
doi:10.1371/journal.ppat.1000837.g002
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Sc
deposition pattern and were of particular interest since their
synaptic core is the site of convergence of the axons of the ORNs
with nerve terminals from the mitral and tufted cells in the
olfactory bulb. Laser scanning confocal microscopy (LSCM) was
used to investigate PrP
Sc deposition in the nerve terminals and
axons of ORNs in the glomerular layer. Dual immunofluorescence
for OMP and PrP
Sc revealed that the core of the glomeruli had
widespread staining for OMP as well as PrP
Sc (Figure 3D to 3F).
There were areas of PrP
Sc deposition that appeared to overlap
with OMP (Figure 3, white arrow #2), but also regions of the
glomerular core that were OMP-negative and were strongly PrP
Sc-
positive (Figure 3, white arrow #1). These findings suggest that the
distribution of PrP
Sc is consistent with the nerve terminals of both
the OMP-positive ORNs and OMP-negative mitral and tufted
cells as they converge in the synaptic-rich glomerular layer.
To investigate the spread of HY TME infection into the nasal
cavity following i.ob. inoculation, LSCM was used to localize
PrP
Sc deposition in the nasal cavity. Dual immunofluorescence for
OMP and PrP
Sc revealed a widespread OMP distribution in both
the OSE and the nerve bundles located in the subepithelial layer
(Figure 4A and 4C). These OMP-positive axons project from the
ORNs in the OSE to the glomerular layer in the olfactory bulb.
PrP
Sc deposition could be found in the OMP-positive OSE, but
was not evident in the nerve bundles (Figure 4B and 4C). At higher
magnification, a clear delineation was found at the transition
between the OMP-positive OSE and the OMP-negative non-
sensory, or respiratory, epithelium in the nasal cavity (Figure 4D
and 4F). PrP
Sc was localized to soma and dendrites of ORNs that
were OMP-positive, but not to cellular structures in the non-
sensory epithelium (Figure 4E to 4F). LSCM for OMP and PrP
Sc
in mock-infected hamster also revealed a clear delineation in OMP
immunofluorescence between OSE and non-sensory epithelium,
but PrP
Sc deposition was not observed in nasal mucosa of normal
hamsters (Figure S3B and S3C). At higher magnification of ORNs,
distinct PrP
Sc deposits were visible in the cell bodies, dendrites,
Figure 3. Distribution of PrP
Sc in main olfactory bulb following HY TME infection. Hematoxylin and eosin staining of olfactory bulb (A) and
PrP
Sc immunohistochemistry (B, brown chromagen and hematoxylin counterstain of nuclei) in adjacent tissue section revealed a strong PrP
Sc pattern
throughout the olfactory bulb including the granule layer (GL), inner plexiform layer (IPL), mitral cell layer (M), outer plexiform layer (OPL), and
glomeruli (G), but not in the outer nerve layer (ONL). Asteriks in panel B illustrate PrP
Sc deposition in a single glomerulus, which is enlarged in panel C
(PG=periglomerular cells). In D to F, double immunofluorescence and laser scanning confocal microscopy was used to demonstrate the relationship
of olfactory marker protein (OMP)(D) and PrP
Sc (E) in a single glomerulus of the olfactory bulb. OMP and PrP
Sc immunofluorescence are merged in
panel F and nuclei were stained with ToPro-3 (blue). White arrow #1 illustrates PrP
Sc immunofluorescence that was surrounded by OMP
immunofluorescence in the glomerulus, while white arrow #2 is an example of PrP
Sc and OMP overlap in the glomerulus. Immunofluorescence
staining and LSCM were performed as described in materials and methods. Scale bar is 100 mmi nA and C and 10 mmi nD.
doi:10.1371/journal.ppat.1000837.g003
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to 4I). A three-dimensional reconstruction of an apical dendritic
knob revealed PrP
Sc deposition within this structure (Video S1),
but PrP
Sc deposition was not observed in the dendritic knobs of
ORNs from normal, mock-infected hamsters in the nasal cavity
(Video S2) or in other locations in the subepithelial layer of HY
TME infected hamsters including the Bowman’s gland, which
secretes mucus into the nasal passages. It was occasionally
observed in the nasal-associated lymphoid tissue as previously
reported [23].
To determine the spatial relationship between OMP and PrP
Sc
in the ORNs, a stack of optical slices of 0.25 um thickness through
the tissue were obtained by LSCM. Deconvolution of LSCM
images and co-localization analysis indicated that there was a
statistical difference in PrP
Sc immunofluorescence in OMP-
positive cells between mock-infected and HY TME-infected
hamsters (see average overlap coefficient in Table 1). The
Manders Overlap Coefficient, M2, was calculated in order to
determine the percentage of PrP
Sc immunofluorescence that co-
localized with the OMP signal in a selected region. The M2 was
determined for three regions of the OSE including the soma,
dendrites, and apical dendrites of ORNs. For each portion of the
ORN there was greater than a 90% co-localization of the PrP
Sc
signal with OMP (M2.0.90, Table 1). Although PrP
Sc deposition
Figure 4. Distribution of PrP
Sc in olfactory sensory epithelium following intra-olfactory bulb inoculation of the HY TME agent. Laser
scanning confocal microscopy of olfactory marker protein (OMP)(A, D, G), PrP
Sc (B, E, H), and for both OMP and PrP
Sc (Merge)(C, F, I). Panels A through
C, D through F, and G through I are the same field of view. In A to C, the olfactory sensory epithelium (OSE or O) and nerve bundles (*) in the
subepithelial layer (SE) express high levels of OMP and the airway lumen (AL) is observed between two opposing OSEs in the nasal turbinate. In D to
F, the OSE is distinct from the nonsensory epithelium (NSE) by the presence of OMP and is separated by a dashed white line at the border between
the two epithelial layers. The soma of an olfactory receptor neuron (ORN) in the OSE is identified by a white arrow and PrP
Sc was only observed in
OMP-positive ORNs and not in the NSE. In G to I, the white arrow points to the soma of an OMP-positive ORN and the yellow arrow indicates the
apical dendrite of an OMP-positive ORN, which sits adjacent to the airway lumen (G). PrP
Sc was present in both the soma and dendrites of ORNs (H, I).
Immunofluorescence staining and LSCM were performed as described above. Scale bar is 100 mmi nA and 10 mmi nD and G.
doi:10.1371/journal.ppat.1000837.g004
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IHC or immunofluorescence at lower magnification, deconvolu-
tion and co-localization analysis of LSCM images revealed that the
average overlap coefficient for PrP
Sc and OMP was statistically
significant between mock-infected and HY TME-infected ham-
sters (Table 1). The M2 coefficient indicated that greater than
80% of the PrP
Sc signal co-localized with OMP immunofluores-
cence in nerve bundles. These findings indicate that HY TME
infection is prominent in the soma and dendrites of ORNs and less
evident in axons in the subepithelial layer of the sensory mucosa
following i.ob. inoculation.
To determine the spatial relationship of HY TME infection to
the nasal airway, LSCM was performed to investigate PrP
Sc
deposition in sensory cilia that project from the apical dendrites of
ORNs into the lumen of the airway. For these studies, an antibody
to adenylyl cyclase III (ACIII) was used since this membrane
protein is located on the cytoplasmic side of the plasma membrane
in the sensory cilia. Dual immunofluorescence staining of the OSE
revealed prominent PrP
Sc deposition in the ORN cell layer and a
more sporadic deposition pattern in the location of the apical
dendrites of the ORNs (Figure 5B). ACIII immunofluorescence
revealed a spatial pattern consistent with the border between the
dendritic knob and lumen of the nasal cavity (Figure 5A) and when
PrP
Sc and ACIII distributions were merged, the PrP
Sc pattern was
consistent with deposition in ACIII-positive cilia (Figure 5C). The
inset in Figure 5A to 5C illustrates a higher magnification of an
ACIII-positive cilia that had evidence for PrP
Sc deposition. The
co-localization of ACIII and PrP
Sc were confirmed by deconvolu-
tion of LSCM images and co-localization analysis (M2.0.90). A
three-dimensional view of dual immunofluorescence for PrP
Sc and
ACIII illustrates PrP
Sc deposition in the dendrites and knobs of
ORNs as well as its overlap with ACIII at the tip of the ORN
knobs (Video S3), but PrP
Sc deposition was not observed in the
ACIII positive cilia in the OSE from normal, mock-infected
hamsters (Figure S3D). These studies suggest that the majority of
PrP
Sc in the region of the apical dendrites co-localize with sensory
cilia and suggest that HY TME infection can be established in the
cilia of ORNs.
The vomeronasal organ (VNO), which is a chemoreceptive
structure at the base of the nasal septum, was another sensory
structure that had evidence of HY TME infection following i.ob.
inoculation. Like the olfactory epithelium, the VNO epithelium
has both a sensory and non-sensory epithelium, but PrP
Sc
deposition was only detected in the sensory epithelium of the
VNO. LSCM revealed that PrP
Sc deposition occurred in the
OMP-positive soma and apical dendrites of vomeronasal receptor
neurons (VRNs), but less frequently to the proximal dendrites in
VRNs (Figure 5D to 5F). The inset indicates a higher
magnification of OMP-positive apical dendrites and PrP
Sc
deposition can be observed both overlapping with OMP and also
extending beyond the OMP region, perhaps in the sensory
microvilli that extend from the VRN dendritic knobs into the
lumen of the vomeronasal cavity. The pattern of PrP
Sc
immunostaining in the vomeronasal sensory epithelium was
similar to that in the OSE where it appeared limited to the soma
and apical dendrites of sensory neurons and not to subepithelial
structures.
Prion infectivity in olfactory bulb and mucosa
To investigate the amount of HY TME infection in the
olfactory mucosa following i.c. and i.ob. inoculation, TME
infectivity in lysates from the olfactory bulb and olfactory mucosa
extracted from nasal turbinates were measured using a hamster
bioassay. The incubation period (mean 6 SEM) for the four
olfactory bulb lysates (6862.3 days) was shorter (p,0.001, Tukey-
Kramer analysis) than the olfactory mucosa lysates (8461.2
days)(Table 2). However, a comparison of the incubation period
for the olfactory bulb and mucosa lysates within a single hamster
revealed a difference for only two of the four hamsters (p,0.001,
Tukey-Kramer analysis)(Table 2, hamster i.c. #1 and hamster
i.ob. #3). A comparison of the i.c., and i.ob. routes of inoculation
revealed a difference in the incubation periods for the olfactory
bulb lysates (p,0.001, Tukey-Kramer analysis). The lysates from
the i.ob. route had a shorter incubation period compared to the
i.c. route (6361.7 days vs. 7463.5 days). However, the route of
inoculation did not effect the time to onset of HY TME following
bioassay of the olfactory mucosa lysates (8261.7 days vs. 8661.4
days), suggesting that the greater replication in the olfactory bulb
following i.ob. inoculation did not result in more TME replication
in the olfactory mucosa compared to the i.c. route.
For the hamster infectivity bioassay, the time interval to the
onset of clinical signs of HY TME is inversely proportional to the
prion titer and this enables calculation of the HY TME titer in the
olfactory bulb and mucosa lysates using the incubation interval
assay [31–33]. These incubation periods correlate to a HY TME
titer of 10
4.9 to 10
8.1 median lethal doses (LD50) per ug protein for
the olfactory bulb and 10
3.7 to 10
4.6 LD50/ug for the olfactory
mucosa, respectively (Table 2). Although the HY TME titer of
individual olfactory bulb lysates ranged from 10
2.2 to 10
4.3 LD50
greater than olfactory mucosa lysates from the same hamsters, the
total amount of TME infectivity for the olfactory mucosa lysates
(10
7.7 to 10
9.2 LD50) was within 100-fold of the olfactory bulb
lysates (10
9.0 to 10
10.7 LD50) in three of four hamsters. In hamster
#3 the total amount of TME in the olfactory bulb infectivity was
10
3.5 LD50 higher than olfactory mucosa lysates (Table 2). These
findings suggest that the olfactory mucosa contains very high levels
of HY TME infection that are only slightly lower than those found
in the olfactory bulb in most cases.
Prion infectivity in nasal lavages
Since high levels of HY TME infectivity were found in both the
olfactory bulb and olfactory mucosa following i.c. and i.ob.
inoculation of hamsters, we investigated the release of prions into
nasal secretions. Nasal lavages were examined in hamsters with
clinical HY TME from five i.c. inoculated (incubation periods
ranging from 71 to 136 days) and five i.ob. inoculated (incubation
periods ranging from 90 to 107 days) hamsters (Table 3). At the
Table 1. Colocalization of PrP
Sc and olfactory marker protein
in olfactory receptor neurons.
ORN Region
a Mock
b HY TME
b M2 values
c
Cell body 0.00360.002 0.15260.009* 0.99
Dendrite 0.00860.004 0.26460.028* 0.99
Dendritic knob 0 0.28160.024* 0.93
Nerve bundle 0.01660.009 0.04560.005* 0.83
aThe individual regions of olfactory receptor neurons (ORN) was determined
following anti-OMP immunofluorescence and confocal images were cropped
to each region of interest prior to deconvolution and co-localization analysis as
described in the materials and methods.
bAverage Overlap Coefficient after Manders 6 SEM, N=27.
cColocalization coefficient M2 indicates the percentage of PrP
Sc that overlaps
with OMP in the region of analysis.
*p-value,0.0001, comparison between mock and HY TME infected tissues
using Welch’s two-sample t-test.
doi:10.1371/journal.ppat.1000837.t001
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Sc distribution at the border of airway lumen of the olfactory and vomeronasal sensory epithelium following intra-
olfactory bulb inoculation of the HY TME agent. Laser scanning confocal microscopy of adenylyl cyclase III (ACIII)(A), olfactory marker protein
(OMP)(D), PrP
Sc (B, E), and for both ACIII or OMP and PrP
Sc (Merge)(C, F). Panels A through C, and D through F are the same field of view. PrP
Sc was
prominent in the OSE including at the border with airway lumen (AL)(B) where it appears to overlap with ACIII (A), which is located on the sensory
cilia that project from the terminal dendrites of ORNs into the AL (C). Boxed area is an inset corresponding to enlarged region indicated by arrow. In D
to F, the soma, dendrites and dendritic knobs of vomeronasal receptor neurons (VRN, white arrows) in the vomeronasal sensory epithelium were
OMP-positive. PrP
Sc was found associated with VRNs in the cell layer and at the border with the vomeronasal airway lumen (VL)(B). Inset illustrates
enlarged area of PrP
Sc deposition in a location consistent with the terminal dendrites of OMP-positive dendritic knobs (C). PrP
Sc deposition was less
frequently observed in the proximal dendrites as they transverse the support cells (sc, can visualize their elongated blue nuclei). Nuclei were stained
with To-Pro 3. Scale bar is 10 mm.
doi:10.1371/journal.ppat.1000837.g005
Table 2. Prion infectivity of olfactory bulb and olfactory mucosa lysates following HY TME inoculation.
Tissue & Hamster
Route of inoculation,
intra-
a
Incubation period,
days ± SEM
Estimated HY TME
titer, LD50 per microgram protein
b
HY TME infectivity,
Total median lethal doses
c
Olfactory bulb #1 cerebral 7064.7
d 10
6.1 10
9.8
Olfactory mucosa #1 cerebral 8562.3
e 10
3.8 10
8.1
Olfactory bulb #2 cerebral 7764.9 10
4.9 10
9.0
Olfactory mucosa #2 cerebral 8661.8 10
3.7 10
7.7
Olfactory bulb #3 olfactory bulb 6160.6
d 10
8.1 10
11.7
Olfactory mucosa #3 olfactory bulb 8562.3
e 10
3.8 10
8.2
Olfactory bulb #4 olfactory bulb 6663.1 10
6.9 10
10.7
Olfactory mucosa #4 olfactory bulb 7961.8 10
4.6 10
9.2
aFollowing inoculation by either route, olfactory bulb and mucosa were collected from hamsters with HY TME, lysates prepared, and 25 mg protein lysate was i.c.
inoculated into each recipient hamster (N=4) in the animal bioassay.
bInfectivity titers were estimated using the incubation interval assay [29,32,33].
cTotal median lethal doses were calculated by multiplying the HY TME LD50 per mg protein by the total amount of protein in each lysate.
d, ep-value,0.001 between olfactory bulb and olfactory mucosa from individual hamster, Tukey-Kramer pair-wise analysis.
doi:10.1371/journal.ppat.1000837.t002
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and prion infectivity in each lavage was measured by hamster
infectivity bioassay. The nasal lavages from the five HY TME
hamsters infected by the i.c. route had a mean incubation period
that ranged from 10862.6 days to 252 days and overall, 22 of the
30 hamsters inoculated with these nasal lavages developed clinical
TME in the hamster bioassay (Table 3). For the nasal lavages from
the i.ob. inoculated group, the mean incubation period ranged
from 12669.0 days to 184610.0 days, and 29 of 30 hamsters
developed clinical disease. A comparison of the incubation periods
of nasal lavage samples from i.c. versus i.ob. inoculated hamsters
did not reveal a difference, 148610.4 versus 15368.8 days. Using
the incubation interval assay to estimate the HY TME titer, the
nasal lavage with the highest infectivity had an incubation period
of 10862.6 days (Table 3), which would correspond to a titer of
approximately 10
3.9 LD50 per ml. Since there was a 100-to-500-
fold dilution of nasal fluid upon collection of nasal lavages by
irrigating with one ml of PBS, it is expected that the titer of
undiluted nasal fluid would be proportionally greater, or as high as
10
5.5 LD50 per ml. The nasal lavage with the least amount of prion
infectivity would correspond to a HY TME titer of approximately
less than one LD50/ml, but a more precise estimate of titer will
require an endpoint dilution analysis since the length of these latter
incubation periods was beyond the linear range of the TME dose-
response curve. The nasal lavages from the age-matched, mock-
infected hamsters did not cause clinical symptoms in recipient
hamsters by 255 days postinoculation (Table 3). These findings
strongly suggest that HY TME infectivity is released from the OSE
possibly via ORNs and subsequently shed into the lumen of the
nasal airway.
To examine nasal lavages for HY TME infectivity using a more
rapid method, samples were analyzed using an in vitro PrP
Sc
amplification method called the Quake Induced Conversion
(QuIC) assay [34,35]. This assay allows the amplification of
femtogram amounts of PrP
Sc in hamster, sheep and human brain
homogenates. During this reaction PrP
Sc induces the conversion of
E. coli derived hamster recombinant PrP
C into a PK-resistant PrP
characterized by a distinct polypeptide pattern. An aliquot of the
same nasal lavage samples obtained from age-matched and HY
TME hamsters used in the animal bioassay experiments (Table 3)
was tested by two consecutive rounds of the QuIC assay (Figure 6).
Western blot analysis revealed that the nasal lavages from HY
TME infected hamsters, which had mean incubation periods
between 126 and 179 days, resulted in PK-resistant PrP
polypeptides of 11 to 13 kDa and 17 kDa (Figure 6, lanes 9, 10,
and 12), while the nasal lavages from mock-infected hamsters did
not (Figure 6, lanes 4, 6, and 7). These PK-resistant polypeptides
are used to discriminate reactions seeded with PrP
Sc from those
only containing normal brain homogenates [34,35]. In some
instances, a mock-infected brain control sample lacking PrP
Sc does
produce only the lower molecular weight PK-resistant PrP
polypeptides, which have a slightly lower molecular weight and
different intensity distribution compared to the HY TME samples
(Figure 6, lane 1 versus lane 2); these lower molecular weight
polypeptides are sometimes observed in PrP
Sc -negative samples
(Figure 6, lane 3) and are not considered to represent a positive
result in the QuIC assay [34,35]. In contrast, 100 femtograms of
purified PrP
Sc resulted in a positive amplification of PrP
Sc
(Figure 6, lane 2). Another control group included 2 ml from a
10
26 dilution of a HY TME-infected brain, which also resulted in
the PK-resistant polypeptide pattern in the QuIC assay (Figure 6,
lane 5). This dilution of hamster brain corresponds to approx-
imately six LD50 of HY TME agent, while additional reactions
from 10
28 and 10
210 dilutions of HY TME brain did not result in
PK-resistant PrP conversion product (Figure 6, lanes 8 and 11).
These results were confirmed in two additional trials of the QuIC
Table 3. Prion infectivity in nasal lavages of HY TME infected hamsters.
Infection Type & Inoculation Route Animal number
Incubation
period, days
Nasal Lavage Bioassay
a
Incubation period,
days ± SEM Affected/Inoculated
HY TME, Intracerebral
HY TME i.c. #17 1 1 6 5 621 5/6
HY TME i.c. #27 3 1 0 8 62.6 6/6
HY TME i.c. #3 129 196620 4/6
HY TME i.c. #4 131 12465.8 6/6
HY TME i.c. #5 136 252 1/6
HY TME, Intra-olfactory bulb
HY TME i.ob. #19 0 1 7 9 613.8 6/6
HY TME i.ob. #29 2 1 2 6 69.0 6/6
HY TME i.ob. #39 2 1 2 8 67.0 6/6
HY TME i.ob. #49 3 1 8 4 610 5/6
HY TME i.ob. #5 107 151621 6/6
Mock, Intra-olfactory bulb
Mock #1 age-match control .255 0/3
Mock #2 age-match control .255 0/3
Mock #3 age-match control .255 0/3
Mock #4 age-match control .255 0/3
aNasal lavages were collected from age-matched or clinical hamsters with HY TME. For bioassay, 50 ml of nasal lavage was inoculated into 3 to 6 hamsters per sample
and the duration until onset of clinical symptoms was recorded as mean 6 standard error of the mean (SEM).
doi:10.1371/journal.ppat.1000837.t003
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effective for detecting HY TME PrP
Sc in nasal lavage samples
containing low levels of TME infectivity.
Discussion
The major findings of this study are 1) prion infection can
replicate to high levels in the olfactory epithelium; 2) prion
infection in the nasal mucosa is primarily in sensory neurons and
PrP
Sc localization to the sensory cilia of ORNs indicates that
infection extends into the airway lumen; and 3) low-to-moderate
levels of prion infectivity can be recovered in nasal lavages from
animals with infection of the olfactory sensory epithelium. The
total amount of HY TME infectivity in the nasal turbinates was at
least 10
8 LD50 and in most cases, was within 100-fold of the
infectivity found in the entire olfactory bulb. This represents a
large amount of prion replication compared to what has been
described for other peripheral tissues (excluding nervous and
lymphoreticular systems) [26,27,36–38] and is most likely due to
the high innervation of the olfactory epithelium. The hamster
OSE has an estimated 20 million ORNs, 9 million of these with
dendritic knobs, which would represent the mature ORN
population [39]. This compares to an estimated 330,000 mitral
and tufted cells in the main olfactory bulb (MOB) of hamsters [39]
and, in small rodents, there are between 5 to 7 million granule cells
in the MOB [40]. So, there are likely a greater number of neurons
in the OSE than the olfactory bulb and this dense concentration of
potential replication sites in the olfactory epithelium could explain
the high HY TME infectivity and PrP
Sc levels in the olfactory
mucosa. These finding are consistent with the high amount of
PrP
Sc in the medial nasal concha of scrapie-infected sheep, which
was within 10-fold of the corresponding brainstem [24], and the
low-to-moderate infectivity titers in the olfactory mucosa of sheep
and goats with clinical scrapie [26,27]. The reported amount of
infectivity in these mucosal lysates, ,100 to 1,000 LD50, was likely
underestimated due to the inefficient nature of the interspecies
murine bioassay used to measure scrapie infectivity [41].
Therefore, the actual titer in mucosa from sheep scrapie are likely
to be closer to those found in HY TME infection of hamsters.
Further support for targeting of the olfactory system in
transmissible prion diseases is found in chronic wasting disease
of deer in which the olfactory system is a prominent target for
PrP
Sc deposition [42]; we have also observed PrP
Sc in the nasal
septum of deer and elk with CWD [28]. Therefore, the olfactory
epithelium appears to be a major mucosal site for prion infection
in natural prion diseases and its role in prion shedding and
transmission needs to be further evaluated.
Although several studies have demonstrated prion infection in
ORNs, evidence suggests that these neurons are not directly
infected by environmental exposure from the airway lumen.
Experimental intranasal inoculation in rodents and ruminants
can cause prion disease [25,43–45], but the route of neuroinva-
sion does not appear to be by direct entry into ORNs and
subsequent spread along their axons to the olfactory bulb since
the initial site of PrP
Sc deposition in the brain is not in the
olfactory bulb [25,43]. Although prion neuroinvasion by the
intranasal route can be independent of lymphoreticular system
infection in some cases [44], the evidence does not support a role
for ORNs as a site of entry into the nervous system. On the other
hand, ORNs do appear to be a target for prion infection
following infection of the brain [23] and hence, infection is likely
due to centrifugal spread of the prion agent along the olfactory
and vomeronasal cranial nerves to the ORNs and VRNs,
respectively [23]. This conclusion is supported in the current
study in which there was widespread PrP
Sc deposition in
glomeruli in the olfactory bulb including at both the OMP-
positive ORN nerve terminals and OMP-negative regions that
likely contain mitral and tufted cell processes. Transynaptic
spread of the HY TME agent from mitral and tufted cells to
ORN terminals in the synaptic-rich glomeruli would be a very
effective mechanism to establish infection throughout the OSE
since the nerve terminals of the 9 million knobbed ORNs
converge at one of the 3,100 glomeruli in the hamster olfactory
bulb [39]. It is estimated that there are between 1,300 and 4,667
ORNs projecting to each glomerulus [39], so infection of mitral
and tufted cells at a single glomeruli can in theory result in
transynaptic spread of infection to a large number or ORNs. The
unique neuroanatomy in the olfactory bulb could serve to rapidly
and efficiently amplify prion infection from a few dozen neurons
in each glomerulus to thousands of ORNs in the OSE.
Establishment of prion infection in ORNs by centrifugal spread
from the olfactory bulb is also consistent with infection of the
olfactory system and OSE in sporadic CJD since in this type of
CJD [22], PrP
Sc deposition appears to have a limited distribution
in peripheral tissues and would not likely gain access to the OSE
from a disseminated peripheral infection [46,47]. We propose
that centrifugal prion agent spread from glomeruli in the
olfactory bulb can result in a logarithmic expansion of prion
infection to the ORNs. This may be the only example of an
amplification of prion replication sites following centrifugal
spread from the central to the peripheral nervous system. An
alternate mechanism for prion infection of olfactory nerves has
been proposed based on PrP
Sc deposition in the perineurium of
the olfactory nerve bundles in scrapie-infected sheep [24]. This
study suggested that spread of the scrapie agent in cerebrospinal
fluid is consistent with the prion distribution to the meningeal
layer of the olfactory nerve as well as a subependymal and
perivascular PrP
Sc deposition pattern [24].
A long-standing, unresolved issue in the natural prion diseases
is the source(s) and route(s) of prion transmission. Historically, it
has been known that scrapie in sheep can be vertically
transmitted and recent studies demonstrate that milk from
Figure 6. Western blot detection of HY TME infection in nasal
lavages using the QuIC assay. Nasal lavages (2 ml) from mock-
(M)(lanes 3, 4, 6, and 7 correspond to the four mock-infected samples
from Table 3) and HY TME (H) -infected hamsters (lanes 9, 10, and 12
correspond to HY TME i.ob. #1t o#3 in Table 3) were subject to two
serial rounds of the QuIC assay in order to detect low levels of PrP
Sc. PK-
resistant PrP polypeptides between 11 and 17 kDa were observed in
the HY TME nasal lavage samples indicating amplification of PrP
Sc.I n
mock-infected nasal lavage samples either no polypeptides or
occassionally lower molecular weight polypeptides (#12 kDa) were
observed, but the latter were not observed in prion-positive control
samples. Controls include mock-infected hamster brain homogenates at
a1 0
22 and 10
26 dilution (lanes 1 and 13, respectively), HY TME hamster
brain at a 10
26,1 0
28,a n d1 0
210 dilution (lanes 5, 8, and 11,
respectively), and 100 femtogram of purified PrP
Sc from 263K scrapie
infected hamster brain (lane 2).
doi:10.1371/journal.ppat.1000837.g006
Prions in Nasal Secretions
PLoS Pathogens | www.plospathogens.org 9 April 2010 | Volume 6 | Issue 4 | e1000837scrapie-infected ewes can transmit disease to lambs from a
scrapie-free flock [12,13]. This likely represents an important
route of prion transmission in scrapie, but horizontal routes
including environmental contamination also have a role in prion
transmission. A role for other bodily fluids in natural prion
transmission in scrapie and CWD has not been firmly established
despite evidence for prion infection in blood, saliva, urine, and
feces as well as in carcasses of deceased deer [16–20]. Clearly,
ruminants will be exposed to saliva, urine, and feces through
direct contact with other hosts or indirectly to a contaminated
environment. However, the role for these fluids is uncertain based
on the low amounts of prion infectivity that were found
[19,26,27,36,48]. Assuming that dose is a major limiting factor
for transmission of a prion infection as it is in almost all
infections, we propose that nasal secretions are a good candidate
for a source of horizontal transmission since moderate levels of
prion infectivity were found in nasal lavages from hamsters with
HY TME. The localization of PrP
Sc to sensory cilia of ORNs,
which form a mat in the mucus layer of the olfactory epithelium,
in this study and recently demonstrated in sCJD [49], as well as
the continual turnover of mature ORNs [50,51] strongly suggest
that shedding of prions into the airway lumen could result in
prion infection of nasal secretions. Disruption of the nasal
epithelium in ruminants from either physical insult, subcutaneous
botfly infestation, or microbial infection could all result in
excessive nasal discharge in sheep or cervids with a preexisting
prion infection of the nasal mucosa, and therefore, lead to an
enhanced shedding of prions into nasal secretions. Evidence that
cofactors could contribute to prion agent shedding from the
olfactory mucosa has been demonstrated in rodents with chronic
kidney inflammation that results in elevated secretion of prion
infectivity in urine [48] as well as in sheep with both mastitis and
scrapie in which PrP
Sc deposition is redirected to the inflamed
mammary gland [52] and may contribute to vertical scrapie
transmission through secretion of prions in milk.
Our findings that HY TME infectivity could be measured in
nasal lavages by animal bioassay and PrP
Sc was amplified using the
QuIC assay indicates that nasal lavages or swabs could be used for
diagnosis of prion diseases. Biopsy of the nasal epithelium has been
used for diagnosis of sporadic CJD by PrP
Sc immunohistochem-
istry [53] indicating the feasibility of prion detection in nasal tissue.
Therefore, analysis of nasal swabs may be an alternate approach
for diagnosis or prion diseases since it is much less invasive than a
tissue biopsy and this site is readily accessible and can be swabbed
multiple times. Given that the QuIC assay could amplify PK-
resistant PrP polypeptides from both prion samples containing
approximately six LD50 of HY TME infectivity and nasal lavages
containing low-to-moderate levels of HY TME infectivity,
evaluation of nasal lavage samples using the QuIC assay warrants
further investigation to determine whether it can provide a new
approach for rapid prion diagnosis.
Materials and Methods
Animal inoculations and tissue collection
Weanling, Syrian golden hamsters (Simonsen Laboratories,
Gilroy, CA) were intracerebrally (i.c.) inoculated with 50 mlo fa
brain homogenate from a normal hamster (i.e. mock-infected) or
a TME-infected hamster containing 10
7.5 intracerebral median
lethal dose (LD50) per ml of the HY TME agent as previously
described [29,31] or intra-olfactory bulb (i.ob.) inoculated with
2 ml of mock or HY TME brain homogenate containing 10
8.5
LD50/ml. For i.ob. inoculations, a minor surgical procedure was
performed on hamsters under general anesthesia (i.e., ketamine-
xylazine mixture). After shaving fur on the snout between the eyes
and a betadine scrub of the skin, a single incision of the skin was
made between the eyes and the skin was retracted. The
subcutaneous fascia was cut and a single hole was made by
gently twisting a 28-gauge needle into the incisive bone a few
millimeters to the lateral side of the midline. A 30-gauge needle
was inserted into the hole and 2 ml of brain homogenate was
slowly injected into the left olfactory bulb. Methaclyrate glue was
used to close the incision. Following inoculation of the HY TME
agent, hamsters were observed three times per week for the onset
of clinical symptoms, which include hyperesthesia, tremors of the
head and trunk, and ataxia. Animals were euthanized at selected
time points postinoculation or in the early stages of clinical
disease.
For collection of tissues for immunohistochemical and immu-
nofluorescence analyses, hamsters were intracardially perfused
with periodate-lysine-paraformaldehyde (PLP) fixative, tissues
dissected (e.g., brain, olfactory bulb, and nasal cavity), and
processed for embedding in paraffin wax as previously described
[44,54]. For bioassay or biochemical analysis of tissues, the brain,
olfactory bulb, and nasal turbinates were dissected and stored at
280uC until use. Nasal lavages were collected following
exsanguination, by exposing the trachea, placing animals in a
vertical position with their feet pointed upward and the head
downward, inserting a 18-gauge needle, with a polished tip, and 1
cc syringe into the trachea, and slowly displacing 1 ml of PBS into
the trachea. A 1.5 ml tube was placed below the nares and
approximately 0.9 ml of PBS was collected; this fraction was
designated the nasal lavage.
Frozen brain, specifically the brainstem and cerebellum, and
olfactory bulb were homogenized in lysis buffer (i.e., 10 mM Tris-
HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.5% deoxycholate,
and 0.5% ipegal detergent) to 10% (wt. vol.) by mincing semi-
frozen tissue with a razor blade followed by trituration with
hypodermic needle tips (18-, 21-, and 25-gauge) attached to a
syringe. The olfactory mucosa was removed from the nasal
turbinates by incubation in digestion buffer (i.e., Hepes, pH 7.5,
10 mM EDTA) containing Liberase/Blenzyme 3 (Roche Diag-
nostics, Indianapolis, IN.) at 50 mg/ml for 15 min at 37uCw i t h
constant shaking. The supernatant was aspirated from the large
pieces of bone and cartilage and an equal volume of lysis buffer
was added and incubated for an additional 15 min at 37uCw i t h
constant shaking. The supernatant was removed and combined
with the supernatant from the Liberase/Blendzyme digestion
step. Complete protease inhibitor (Roche Diagnostics, Indiana-
polis, IN.) was added and samples stored at 280uC. Protein
concentration in tissue homogenates was measured using the
micro-BCA assay (Pierce Protein Research, Rockford, IL).
Alternatively, olfactory bulb and olfactory mucosa were homog-
enized in lysis buffer using a Bullet Blender (Next Advance,
Averill Park, NY) and glass or zicronium beads. Enrichment for
PrP
Sc from lysates was also performed as previously described
following addition of N-lauroylsarcosine, differential ultracentri-
fugation in a Beckmann Optima TL-100 (Beckman Coulter
Instruments, Fullerton, CA.), and limited proteinase K digestion
[31,54].
Animal bioassay for TME infectivity
For bioassay of olfactory bulb and olfactory mucosa, 25 mgo f
protein from tissue lysates were i.c. inoculated into each hamster.
To measure the amount of TME infectivity in the nasal lavage,
50 ml of each sample was i.c. inoculated into four to eight Syrian
hamsters and the time to onset of clinical symptoms was recorded.
HY TME titer is inversely proportional to the incubation period
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reported [31–33].
Western blot
For analysis of PrP
C and total PrP (i.e., PrP
C and PrP
Sc), 50 to
75 mg of protein per sample was used, while for PrP
Sc, 100 ug of
protein was digested with 10 U/ml of proteinase K (PK)(Roche
Diagnostics) in 0.1 ml of lysis buffer at 37uC for 1 hr. Samples
were analysed on a 12% MOPS NuPAGE gel (Invitrogen,
Carlsbad, CA) and proteins were transferred to PVDF membrane
and incubated with monoclonal anti-PrP 3F4 antibody (gift of V.
Lawson, National Institute of Allergy and Infectious Diseases,
Rocky Mountain Laboratories, Hamilton, MT) at a 1:40,000
dilution for detection of hamster PrP. To measure for the presence
of olfactory receptor neurons, 50 to 75 mg of protein per sample
was analyzed by western blot using an anti-olfactory marker
protein (OMP) antibody (Wako Chemicals, Richmond, VA.) at a
1:25,000 dilution. The detection system included incubation with
anti-mouse or anti-donkey IgG alkaline phosphatase conjugate
(Promega Corporation, Madison, WI) at a dilution of 1:20,000.
Blots were developed using CDP-Star substrate (Applied Biosys-
tems, Foster City, CA) and imaged with a Kodak Image Station
2000MM (Eastman Kodak Company, Rochester, NY). The
molecular weight of immunoreactive polypeptides was estimated
using the 1D Kodak image software and the Magic Mark protein
ladder (Invitrogen) were used as standards.
Quaking Induced Conversion Assay (QuIC) for PK-
resistant PrP
For amplification of low levels of PrP
Sc in nasal lavages the QuIC
assay was performed. The QuIC assay is a modification of a
published method for amplification of PK-resistant PrP that was
based on the protein-misfolding cyclic amplification method [34,35].
Briefly, 2 ml of control and samples from HY TME-positive hamsters
were incubated in 96 mL buffer containing 10 mgo ff u l ll e n g t h( a a
23–231) hamster recombinant prion protein (aa 23–231) that was
cloned and expressed in E. coli. The reaction is incubated at 50uCf o r
8 hours with intermittent shaking (i.e. cycles of 1 min shaking and
1 min rest) using an Eppendorf Thermomixer R set at 1500 rpm. A
second round of the QuIC assay was performed by removing a 2 ml
aliquot of the reaction mixture and repeating the reaction. Following
the second round, samples are digested with 4 mg/ml PK at 37uCf o r
1 hr and analyzed by Western blot using anti-PrP R20 rabbit
polyclonal antibody [34,35]. Control samples included 100 fg of
PrP
Sc that was purified from the brain of clinical hamsters infected
with the 263K strain of scrapie as well as serial 10-fold dilutions of
brain homogenate from mock and HY TME inoculated hamsters.
PrP
Sc immunohistochemistry
For PrP
Sc analysis, olfactory bulb and skulls containing the nasal
cavity were collected and PrP
Sc immunohistochemistry (IHC) was
performed as previously described [23,44]. Briefly, animals were
intracardially perfused with PLP fixative followed by immersion
fixation in PLP (5 hours for olfactory bulb and 24–36 hours for
skulls containing the nasal cavity and olfactory bulb). Following
immersion fixation, decalcification of skulls was performed by
immersion in 10% formic acid or 0.5 M EDTA (tetrasodium salt)
as previously described [23,44]. Once bone was decalcified, the
nasal cavity was cut into coronal pieces prior to processing and
embedding in paraffin wax. Tissues from a minimum of three
animals per group were analyzed. All tissue sections were
subjected to antigen retrieval by treatment with formic acid
(99% wt. vol.) for 10 minutes. Tissue sections were successively
incubated with anti-PrP monoclonal 3F4 antibody overnight at
4uC, then incubated with horse anti-mouse biotinylated secondary
antibody (1:400; Vector Laboratories, Burlingame, CA) at room
temperature for 30 minutes, followed by streptavidin-horseradish
peroxidase (HRP) at room temperature for 20 minutes. PrP
Sc was
visualized by localization of HRP activity with DAB+ (Dako,
Carpinteria, CA). Tissue sections were counterstained with
hematoxylin and cover slip mounted with Aquamount (Lerner
Laboratories, Pittsburgh, PA) for viewing with a Nikon Eclipse
E600 microscope. Controls for PrP
Sc IHC included the use of
mock-infected tissues and substituting a similar concentration of
murine IgG isotype control for the anti-PrP 3F4 monoclonal
antibody. A minimum of 30 sections throughout the thickness of
the tissue was examined for each animal.
PrP
Sc dual immunofluorescence
PrP
Sc immunofluorescence staining was combined with immu-
nofluorescence for olfactory marker protein (OMP) or adenylyl
cyclase III (ACIII)(Santa Cruz Biotechnology, Santa Cruz, CA.) as
described in Table 4. Detection of primary antibodies was
performed by incubation with either horse anti-mouse IgG
conjugated to biotin followed by a Alexa Fluor 488 streptavidin
conjugate (Molecular Probes, Portland, OR) at a 1:400 dilution for
detecton of PrP
Sc, and either donkey anti-goat antibody
conjugated to Alexa Fluor 594 antibody (1:800; Molecular Probes,
Portland, OR) or goat anti-rabbit antibody conjugated to Alexa
Fluor 568 antibody (1:800; Molecular Probes, Portland, OR). The
nuclear counterstain ToPro-3 (Molecular Probes, Portland, OR)
was applied to some tissue sections at a 1:2,000 dilution for
10 min. Mowiol mounting medium was used to cover slip tissue
sections. Tissues from a minimum of three HY TME-infected
animals and three mock-infected animals were examined for each
staining procedure.
Table 4. Primary antibodies used to investigate HY TME infection in olfactory mucosa by laser scanning confocal microscopy.
Antibody
Host
species Class Dilution Antibody Reactivity in Nasal Cavity Source (Location) Reference
Olfactory marker protein
(OMP)
Goat Polyclonal 1:750 Mature olfactory receptor neurons (ORNs) and
vomeronasal receptor neurons (VRNs); soma,
dendrites, axons, and terminals
Wako Chemicals
(Richmond, VA)
[56]
Adenylyl cyclase III (ACIII) Rabbit Polyclonal 1:1,600 Sensory cilia of mature ORNs Santa Cruz
Biotechnology (Santa
Cruz, CA.)
[57]
Prion Protein Murine Monoclonal 1:400 Prion protein with 3F4 epitope Gift from Victoria
Lawson
[58]
doi:10.1371/journal.ppat.1000837.t004
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Images were visualized using a Zeiss LSM 510 Meta confocal
system equipped with a Zeiss Plan-Apochromat 66 3 / N A1 . 4 0a n d
6100/NA 1.2 oil objectives. Double immunofluorescence was
imaged after excitation of Alexa Fluor 488 with an Argon laser at a
wavelength of 488 nm, and excitation of Alexa Fluor 568 or 594 with
a Helium/Neon laser at a wavelength of 543 nm as previously
described [23]. Images were scanned sequentially to minimize
crosstalk between channel and the pinhole aperture was adjusted to
1.0 airy units for both channels while controlling for identical pinhole
diameters and subsequent optical slice thickness. Individual images
for stacks were at either 0.10 or 0.25 micron per optical slice.
Deconvolution of confocal images
Deconvolution was performed using Huygens Essential software
(version 2.7, Scientific Volume Imaging, Hilversum, The Nether-
lands). Using the crop tool, the region of interest (e.g. olfactory
sensory epithelium, cell body, axon, dendrite, cilia) within the image
waschosenfordeconvolution.Asimilarsized regionwas analyzed for
each comparison. A maximum likelihood estimation algorithm was
applied for deconvolution of the confocal images. All images were
deconvolved with identical estimations of relative background and
signal to noise ratio. Deconvolution was performed on a minimum of
nine image slices per individual hamster tissue, with a total of N=27
for each morphological area in each hamster group.
Colocalization analysis of confocal images
After deconvolution, digital images were evaluated for coloca-
lization using the Colocalization Analyzer tool of Huygens
Essential software, which provides information about the amount
of spatial overlap between structures in different data channels, as
previously described [23]. Colocalization coefficients were gener-
ated by the analyzer module and included the Manders overlap
coefficient (MOC) and the M2 coefficients. MOC indicates the
overlap of signals in image pairs, and has a value range of 0 to 1
with a value of 0 indicating no colocalization and a value of 1
indicating that all voxels (volumetric pixels) in both channels
colocalize. Additional analysis was performed on HY TME-
infected tissues by division of the MOC into the M2 sub-
coefficients. This coefficient was calculated for voxel ranges
defined by an area of interest in the image, and are insensitive
to differences in signal intensities. The coefficient M2 is used to
describe the contribution of channel 2 (i.e. PrP
Sc immunofluores-
cence) to the colocalized area with channel 1 (i.e. OMP or ACIII
immunofluorescence). For calculation of coefficients, a minimum
of N=27 for each region of interest was used for each comparison
of mock and HY TME hamsters.
Statistical analysis
The average MOC of the confocal images generated from
HY TME-infected tissues were compared to the average MOC
of images generated from mock-infected tissues to evaluate the
probability (p-value) that the co l o c a l i z a t i o no b s e r v e di nt h e
experimental samples was greater than would be expected by
chance. Statistical comparisons of MOC were performed using
Welch’s two-sample t-test using R software (R Foundation for
Statistical Computing, Vienna, Austria). M2 values for HY
TME were reported only when a statistical difference in MOC
was found between mock- and HY TME-infected tissues. For
analysis of HY TME incubation periods, a Tukey-Kramer
analysis of pair-wise differences among experimental groups
was performed and p-value,0.001 was considered to be
significant.
Ethics statement
All procedures involving animals were approved by the
Montana State University IACUC and were in compliance with
the Guide for the Care and Use of Laboratory Animals [55]; these
guidelines were established by the Institute of Laboratory Animal
Resources and approved by the Governing Board of the U.S.
National Research Council.
Supporting Information
Figure S1 Western blot for the amount of the cellular prion
protein in olfactory bulb and olfactory mucosa. Lysates from
normal hamster olfactory bulb (A) and olfactory mucosa from
nasal turbinates (B) were analyzed by two-fold serial dilution
starting with 25 mg protein (lane 1) and ending at 0.0975 mg
protein (lane 9). From this representative Western blot (anti-PrP
SAF-32 antibody), it is estimated that PrP
C could be detected in
0.39 mg of protein from olfactory bulb lysates (lane 7) and 3.12 mg
of protein from olfactory mucosa lysates (lane 4). By dilution
analysis there was 8-fold more PrP
C in the olfactory bulb than the
olfactory mucosa. This analysis was performed for three individual
hamsters and yielded similar results. The distinct PrP
C polypeptide
pattern between these two tissues is also apparent between panel A
and B.
Found at: doi:10.1371/journal.ppat.1000837.s001 (0.37 MB TIF)
Figure S2 Western blot for cellular prion protein in olfactory
bulb and olfactory mucosa following deglycosylation. Lysates from
normal hamster olfactory bulb (OB) and olfactory mucosa
(OM)(lanes 1 to 4) were enzymatically deglycosylated with PNGase
F (lanes 5 to 8) according to the manufacturer’s instructions (New
England Biolabs, Beverly, MA). SDS-PAGE and Western blot
with anti-PrP 3F4 monoclonal antibody was performed as
described in Materials and Methods. To the left of lane 1, the
bracket ([) indicates polypeptides between 33.8 and 37 kDa that
were prominent in the olfactory bulb lysates (lanes 1 and 2), but
not in the olfactory mucosa lysates (lanes 3 and 4). To the right of
the panel, the asterik (*) indicates the major prion protein
polypeptide at 27.7 kDa that was present in both olfactory bulb
and olfactory mucosa lysates following PNGase F digestion (lanes 5
to 8). This finding indicates that PrP
C from the olfactory bulb and
mucosa have a similar amino acid backbone, but that there are
differences in N-linked glycosylation between these two olfactory
tissues. The amount of protein per lane was 80 mg (lanes 1, 2, 7,
and 8), 100 mg (lanes 3 and 4), and 12.5 mg (lanes 5 and 6). Marker
polypeptides (M) correspond to 20, 30, and 40 kDa.
Found at: doi:10.1371/journal.ppat.1000837.s002 (0.74 MB TIF)
Figure S3 PrP
Sc immunostaining in olfactory bulb and olfactory
mucosa of normal, mock-infected hamsters. PrP
Sc immunohisto-
chemistry (A) and laser scanning confocal microscopy for olfactory
marker protein (OMP)(B), PrP
Sc (C), or adenylyl cyclase III
(ACIII) and PrP
Sc (D) from normal, age-matched hamsters. In A,
PrP
Sc immunohistochemistry (brown chromagen and hematoxylin
counterstain of nuclei) in the olfactory bulb indicate the absence of
staining in the granule layer (GL), mitral cell layer (M), outer
plexiform layer (OPL), and glomeruli (G) from normal hamsters.
Panels B and C are the same field of view. In B, in the olfactory
sensory epithelium (OSE) there was a high level of OMP
expression (red) in the soma and dendrites of olfactory receptor
neurons, but OMP expression was not found in the non-sensory
epithelium (NSE). The border between the OSE and NSE is
demarcated by dashed white line. In C, PrP
Sc immunofluores-
cence (green) did not reveal any reactivity; nuclei were
counterstained with ToPro-3 (blue). In D, the OSE was
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Sc (green) and
counterstained with ToPro-3 (blue). The dendritic knobs (arrow)
contain strong ACIII immunofluorescence at the edge of the
airway lumen (AL), but PrP
Sc deposition was not observed in
normal hamster OSE. Scale bar in panels A, C, and D are 10, 50,
and 10 microns, respectively. Immunostaining and microscopy
techniques are similar to those used in Figures 3, 4, and 5, and are
described in the Materials and Methods.
Found at: doi:10.1371/journal.ppat.1000837.s003 (2.13 MB TIF)
Video S1 Video of a three-dimensional reconstruction of a
dendritic knob following immunofluorescence staining for olfac-
tory marker protein and PrP
Sc in the olfactory sensory epithelium
of a HY TME-infected hamster. Laser scanning confocal
microscopy of olfactory marker protein (OMP)(red, top panel),
PrP
Sc (green, middle panel), and for both OMP and PrP
Sc (bottom
panel) in the same field of view was performed as described in
Figure 4. LSCM image stacks (0.10 mM optical slice) through the
thickness of the tissue were used to generate a three-dimensional
reconstruction of an individual dendritic knob. This movie
illustrates a 360u stereoview of the dendritic knob (OMP
immunofluorescence) and PrP
Sc located within the dendritic knob
of an olfactory receptor neuron.
Found at: doi:10.1371/journal.ppat.1000837.s004 (9.35 MB AVI)
Video S2 Video of a three-dimensional reconstruction of a
dendritic knob following immunofluorescence staining for olfac-
tory marker protein and PrP
Sc in the olfactory sensory epithelium
of a normal, mock-infected hamster. Laser scanning confocal
microscopy of olfactory marker protein (OMP)(red, top panel),
PrP
Sc (green, middle panel), and for both OMP and PrP
Sc (bottom
panel) in the same field of view was performed as described in
Figure 4. LSCM image stacks (0.10 mM optical slice) through the
thickness of the tissue were used to generate a three-dimensional
reconstruction of an individual dendritic knob. This movie
illustrates a 360u stereoview of the dendritic knob (OMP
immunofluorescence), but no PrP
Sc immunofluorescence is evident
in this structure from normal hamsters.
Found at: doi:10.1371/journal.ppat.1000837.s005 (7.97 MB AVI)
Video S3 Video of a three-dimensional reconstruction of a
dendritic knob following PrP
Sc and ACIII immunofluorescence in
the dendrites and cilia of olfactory receptor neurons following HY
TME infection. Laser scanning confocal microscopy and immuo-
fluorescence staining was performed for PrP
Sc (green) and ACIII
(red) as described in Figure 5. Image stacks (0.25 mM optical slice)
through the thickness of the olfactory sensory epithelium were
used to generate a three-dimensional reconstruction of the
dendrites and dendritic knob of olfactory receptor neurons. This
movie illustrates a 360u view of the spatial relationship of PrP
Sc
and ACIII in the dendrites and sensory cilia of olfactory receptor
neurons.
Found at: doi:10.1371/journal.ppat.1000837.s006 (4.22 MB AVI)
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